Today: 7 February 2026
Subscribe

Lockheed Martin stock rises after missile flight test as Pentagon motor deal keeps defense names in focus

Lockheed Martin stock rises after missile flight test as Pentagon motor deal keeps defense names in focus

New York, January 14, 2026, 15:33 EST — Regular session Lockheed Martin (LMT) shares climbed roughly 2.3% Wednesday, closing at $571.40, while the SPDR S&P 500 ETF (SPY) dipped around 0.8%. The stock fluctuated between $553.74 and $578 during the session. Investors are zeroing in on clear evidence that major defense contractors can convert demand into actual output, particularly in missiles and air defense. This focus has been fueling the sector’s gains, even when the broader market wobbles. On Tuesday, the Pentagon announced a $1 billion investment in L3Harris Technologies’ expanding rocket-motor division, aiming to lock down a reliable supply
14 January 2026
·····
Lumentum stock slides late Wednesday as tech selloff hits “AI optics” names ahead of earnings

Lumentum stock slides late Wednesday as tech selloff hits “AI optics” names ahead of earnings

New York, January 14, 2026, 15:44 EST — Regular session Lumentum Holdings Inc shares dropped 8.6% to $330.40 in late trading Wednesday, slipping further after hitting $363 earlier in the day. The optical components maker continues to see volatile moves. The selloff is significant since Lumentum serves as a high-beta proxy for data-center expansions, with its shares often swinging wildly when investors pull back from tech. With earnings around the corner, traders are viewing price moves more as shifts in positioning than fresh news. U.S. stocks dipped Wednesday, with tech and financial sectors dragging the Nasdaq down over 1%, as
14 January 2026
·····
Dave Inc stock tumbles 12% as Trump-backed swipe-fee bill puts fintech fees in focus

Dave Inc stock tumbles 12% as Trump-backed swipe-fee bill puts fintech fees in focus

New York, Jan 14, 2026, 15:32 EST — Regular session Shares of Dave Inc (DAVE.O) dropped 12.5% to $185.35 in afternoon trading Wednesday, after hitting a high of $212.40 earlier. The stock slipped $26.37 from Tuesday’s close, with roughly 765,000 shares changing hands. The slide follows Washington’s move to bring card fees back under scrutiny. On Tuesday, Senators Dick Durbin and Roger Marshall reintroduced the Credit Card Competition Act, with Durbin’s office confirming President Donald Trump’s support for the bill. For Dave, the politics hit a tangible line item. A quarterly filing reveals the company collects “interchange” fees from customers
14 January 2026
····
RTX stock rises as Airbus flags “very, very late” Pratt & Whitney engine deliveries

RTX stock rises as Airbus flags “very, very late” Pratt & Whitney engine deliveries

New York, Jan 14, 2026, 15:18 EST — Regular session RTX Corp shares climbed roughly 1.6% to $197.29 on Wednesday, hitting a high of $198.00 and dipping to a low of $192.88 during the session. The stock had closed at $194.08 previously. The bounce followed fresh concerns in commercial aerospace after Airbus flagged that engine shipments from RTX’s Pratt & Whitney remain “very, very late.” The planemaker also noted it hasn’t settled with the U.S. supplier on how many engines it requires “for the foreseeable future.” Airbus reported delivering 793 aircraft in 2025, with 607 of those being A320neo-family jets.
14 January 2026
·········
Navan stock slides nearly 11% as law-firm probes mount; what investors watch next

Navan stock slides nearly 11% as law-firm probes mount; what investors watch next

New York, Jan 14, 2026, 3:36 p.m. EST — Regular session. Navan shares dropped almost 11% to $15.38 in late afternoon trading Wednesday, deepening a volatile stretch for the corporate travel-and-expense software company since its Nasdaq debut. Airbnb, Expedia and Booking Holdings also slipped, though their declines were more modest. This move is significant since Navan remains stuck in the market’s “new IPO” penalty box. Its initial public offering was priced at $25 back in late October, but the stock has frequently slipped below that mark as investors gauge how much growth they’re ready to back in a company linked
14 January 2026
·····
Impinj stock slides on preliminary Q4 update as PI traders eye Feb. 5 earnings

Impinj stock slides on preliminary Q4 update as PI traders eye Feb. 5 earnings

New York, January 14, 2026, 15:20 ET — Regular session underway. Impinj shares dropped 12.7% to $174.28 in Wednesday afternoon trading following a preliminary fourth-quarter update that aligned with its earlier guidance. The stock hit a low of $171.42 after starting the day at $192.28. Impinj forecasted fourth-quarter 2025 revenue toward the top of its earlier $90.0 million to $93.0 million range, with adjusted EBITDA expected to surpass the midpoint of the $15.4 million to $16.9 million guidance. The company noted these are preliminary, unaudited numbers and plans to release full fourth-quarter and annual results after U.S. markets close on
14 January 2026
·····
Reddit stock slips as insider sales surface, even after Evercore starts RDDT with $320 target

Reddit stock slips as insider sales surface, even after Evercore starts RDDT with $320 target

New York, Jan 14, 2026, 15:16 EST — Regular session Reddit shares dropped roughly 2.5% on Wednesday, erasing some earlier gains following regulatory filings revealing stock sales by two senior executives. The stock traded near $252.52, after fluctuating between $246.85 and $259.62. The disclosures come at a hectic time for the newly public social media firm, with daily trading sharply reactive to any news related to monetisation—whether ads, new formats, or the worth of its data for AI. Evercore ISI kicked off coverage this week with a bullish stance, saying Reddit has ample opportunity to convert its engagement into revenue.
14 January 2026
·····
Trip.com stock sinks nearly 18% after China antitrust probe notice — what investors watch now

Trip.com stock sinks nearly 18% after China antitrust probe notice — what investors watch now

New York, January 14, 2026, 15:03 (EST) — Regular session Shares of Trip.com Group Limited’s U.S.-listed depositary receipts dropped 17.7% to $62.26 in Wednesday afternoon trading. The company revealed it is under investigation by China’s market regulator. Trip.com (Nasdaq: TCOM; HKEX: 9961) said it will cooperate fully and assured that its operations continue as usual. (PR Newswire) This shift highlights just how fast regulatory concerns can upend valuations for China-linked platform firms, despite months of upbeat sentiment on travel demand. China’s State Administration for Market Regulation (SAMR) has launched an investigation into Trip.com, suspecting it of abusing its dominant market
14 January 2026
·····
Praxis Precision Medicines (PRAX) stock jumps after Devinsky hire as FDA filings loom

Praxis Precision Medicines (PRAX) stock jumps after Devinsky hire as FDA filings loom

New York, January 14, 2026, 14:54 EST — During regular session Shares of Praxis Precision Medicines jumped roughly 8% on Wednesday, bucking the weaker trend in the broader market. By mid-afternoon, the Nasdaq-listed biotech was trading at $303.23, up $22.40. The move came after Praxis announced late Tuesday it hired epilepsy expert Dr. Orrin Devinsky for a new head of clinical strategy role. Steven Petrou, president of research and development, said Devinsky’s choice to join “reflects the strength of our scientific approach and long-term strategy.” (GlobeNewswire) Timing is crucial since investors zero in on regulatory filings that can shift a
14 January 2026
····
Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

NEW YORK, Jan 14, 2026, 15:10 EST — Regular session Pfizer Inc shares climbed about 2% to $25.65 on Wednesday following CEO Albert Bourla’s remarks on the company’s push into the rapidly expanding cash-pay obesity drug market. “We are all in on obesity,” Bourla told reporters at the J.P. Morgan Healthcare Conference. Pfizer plans to launch 10 Phase 3 trials for its Metsera obesity compounds by the end of 2026, aiming to fuel future growth. The company still doesn’t expect revenue growth to return until 2029, as it navigates patent expirations and a slowdown in COVID-era sales. (Reuters) The shift
14 January 2026
····
Applied Digital stock slips after director flags share sale — what APLD investors watch next

Applied Digital stock slips after director flags share sale — what APLD investors watch next

New York, January 14, 2026, 15:13 EST — Regular session Shares of Applied Digital dropped Wednesday following a director’s announcement of an upcoming stock sale. Though a minor filing, it rattled the notably volatile stock. The shares slipped 3.3% to $35.51 in afternoon trading, having reached $36.85 earlier in the day. Timing is key. Applied Digital has been moving like a momentum play, with news—whether positive or negative—carrying outsized impact. This sector demands heavy capital upfront. Large data-center projects drain funds fast, and the market often reacts sharply when financing conditions or sentiment change. A Form 144 filed Monday revealed
14 January 2026
···
Sasol stock jumps 6% as oil climbs and South Africa tariff talks heat up

Sasol stock jumps 6% as oil climbs and South Africa tariff talks heat up

New York, Jan 14, 2026, 14:40 EST — Regular session Sasol Limited’s U.S.-listed shares jumped roughly 6.4% to $7.52 on Wednesday, hitting $7.53 at one point—marking their best level in at least a year. This gain stood out against a weaker broader U.S. market in afternoon trading. (https://www.reuters.com/markets/companies/SSL/) The jump matters because Sasol’s earnings hinge on crude prices and the rand: oil influences fuel and chemical costs, while currency moves affect how dollar-based sales translate locally. Traders are also watching South Africa’s fuel demand, which has shown erratic data. This week stands out because the forces at play are tugging
14 January 2026
···
1 … 651 652 653 654 655 … 2,713

Stock Market Today

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop